Loading page...
Loading page...
This round is closed. The next round and similar open calls are listed below. Synced from the EU Funding & Tenders Portal on 9 November 2026.
This call is closed. These open or upcoming calls fund the closest work.
Projects the EU funded under this call, with the organisation that led each one.
VIRGILIUSValue-driven Integrated Guidance and Implementation Laboratory for Innovative unified paediatric orphan medical devices
Led by Universita Cattolica del Sacro Cuore · Italy · 2026 · Official record ↗
DIGIPADIGITAL BIOMARKERS AND INTELLIGENT ASSESSMENT STRATEGIES OF MOTOR ABILITIES IN PEDIATRIC ATAXIA
Led by Ospedale Pediatrico Bambino Gesu · Italy · 2026 · Official record ↗
EUPOPMEDEUropean Platform for Orphan and Paediatric MEdical Devices
Led by Universiteit Twente · Netherlands · 2026 · Official record ↗
Based on projects the EU funded on the same subject in this programme.
Each one links to its EU funding record and the partners it works with: a starting list for building a consortium.
This action is intended to promote the development of innovative orphan devices especially for paediatric patients, with a particular focus on devices responding to unmet medical needs.
This action aims to support innovation in the field of medical devices by supporting non-profit organisations or consortia that provide a platform for academic bodies, scientific societies, developers of devices, in particular SMEs, and NGOs with a specific interest in innovative medical devices to help foster and guide the development of orphan devices, in particular in areas of unmet medical needs and paediatric patients.
A wide range of activities can be funded that support, among other things, the development, design, production and distribution or orphan devices, including intellectual property advising, prototyping, engineering, laboratory and animal testing, grant-writing, and clinical investigation design.
The eligible entities should facilitate the development, production, and distribution of orphan devices, in particular for paediatric patients by:
a) mapping unmet medical needs that could be addressed by orphan devices;
b) encouraging innovation and connecting relevant players (e.g., academia, scientific societies, users) with orphan device ideas with potential manufacturers;
c) mentoring and managing orphan device projects through the development process, including product identification, prototype design, device development, and marketing;
d) connecting developers of innovative devices and physicians to existing financing resources;
e) assessing the scientific and medical merit of proposed orphan device projects;
f) gathering and evaluating pre-clinical data to support the safety and/or performance of the orphan device; g) providing assistance and advice as needed on business development, personnel training, prototype development, intellectual property protection and post-marketing needs;
h) advising about regulatory requirements to device developers in support of achieving CE marking for the orphan devices; and
i) supporting the demonstration of conformity with the relevant requirements laid down in Regulation (EU) 2017/745 or Regulation (EU) 2017/746 with a view to allowing the CE marking of the product building on the guidance MDCG 2024-10 including the scientific advice procedure from the expert panels on medical devices
1. Admissibility Conditions: Proposal page limit and layout
described in section 5 of the call document.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible Countries
described in section 6 of the call document.
3. Other Eligible Conditions
described in section 6 of the call document.
4. Financial and operational capacity and exclusion
described in section 7 of the call document.
5a. Evaluation and award: Submission and evaluation processes
described section 8 of the call document and the Online Manual.
5b. Evaluation and award: Award criteria, scoring and thresholds
described in section 9 of the call document.
5c. Evaluation and award: Indicative timeline for evaluation and grant agreement
described in section 4 of the call document.
6. Legal and financial set-up of the grants
described in section 10 of the call document.
Call document and annexes:
Call document
Call info session
EU4H-2026-SANTE-PJ Info session - Recording, slides and FAQs will remain available under the same link.
Application form templates
Standard application form (EU4H) — the application form specific to this call is available in the Submission System
Detailed budget table (EU4H)
Model Grant Agreements (MGA)
EU4H MGA
Additional documents:
EU4H Work Programme
GNI per capita - to be used to determine Exceptional Utility
EU4H Regulation 2021/522
EU Financial Regulation 2024/2509
Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment
EU Grants AGA — Annotated Model Grant Agreement 
Funding & Tenders Portal Online Manual 
Funding & Tenders Portal Terms and Conditions 
Funding & Tenders Portal Privacy Statement
Confirm the current call documents and submission conditions with the funding authority.
View on EU portal ↗Source: EU Funding & Tenders Portal · synced 2026-11-09
A free account keeps your shortlist and sends deadline reminders. The EUACC connector brings this call, its FAQs, past winners and similar calls into Claude or ChatGPT, so you can check fit and draft with sources.